Back to results
US 2012/0251478 A1Published application
Method for treatment of a glomerular disease comprising administration of anion exchange resin
OwnerMasahiko YAMAMORIinventor
Life of this patent
Estimating the term…
Abstract
Provided is a novel prophylactic and/or therapeutic agent for glomerular disease wherein a pharmaceutically acceptable anion exchange resin, typified by colestimide, is an active ingredient thereof.
Claims9
1-16. (canceled)
A method for treatment of a glomerular disease, comprising administering a therapeutically effective amount of colestimide to a patient in need thereof, wherein the glomerular disease is diabetic nephropathy or IgA nephropathy.
Dependencies are inferred from the claim text.